Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
10/2003
10/02/2003WO2003080046A1 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane nmda, 5ht3, and neuronal nicotinic receptor antagoni sts
10/02/2003WO2003080022A2 Analgesics for nasal administration
10/02/2003WO2003080021A2 Formulation comprising buprenorphine
10/02/2003WO2003079997A2 Prostaglandin f2 alpha analogs in combinaiotn with antimicrobials for treating glaucoma
10/02/2003WO2003049747A8 Pharmaceutical composition for use in ophthalmology and rhinology
10/02/2003WO2003044015A3 Substituted heteroarylalkanoic acids and their use as aldose reductase inhibitors
10/02/2003WO2003042173A8 Nk1 antagonists
10/02/2003WO2003018031A3 Single dose azithromycin for treating respiratory infections
10/02/2003WO2002092759A3 Molecules for disease detection and treatment
10/02/2003WO2002055481A8 Prodrugs of excitatory amino acids
10/02/2003WO2002043722A3 Copper chelators for treating ocular inflammation
10/02/2003WO2002000656A3 Pirazino '1$m(1)2$m(1) :1, 6! pyrido '3,4-b! indole derivatives
10/02/2003US20030187289 A biphenyl-alkyloxy-benzoylamino-propionic acid or amide derivatives; treating thrombosis, cardiovascular disorders, arteriosclerosis, inflammation, tumor, osteoporosis, angioplasty aftertreatment
10/02/2003US20030187276 Hydrophobic polyamine analogs and methods for their use
10/02/2003US20030187260 Thienopyrimidines
10/02/2003US20030187257 Phosphodiesterase inhibitor; antiinflammatory agnets, autoimmune disease; antihistamine agents; skin disorders
10/02/2003US20030187058 Synergistic mixture of lipoic acid and another fatty acid; antidiabetic agents
10/02/2003US20030187047 Vision defects; non-insulin diabetic agents; impotency; dietetics
10/02/2003US20030187024 Vision disorders; antiinflammatory agents; autoimmune disease; anticancer qgents; skin disorders
10/02/2003US20030187020 Chemical compounds
10/02/2003US20030187007 Inhibitors of protein kinase for the treatment of disease
10/02/2003US20030187004 Central nervous system disorders; Alzheimer's disease
10/02/2003US20030186996 Angiogenesis inhibitors
10/02/2003US20030186994 Anticholesterol agents; cardiovascular disorders
10/02/2003US20030186989 Antihistamines; respiratory system disorders
10/02/2003US20030186981 Antiinflammatory agents; osteoporosis; rheumatic diseases; autoimmune diseases
10/02/2003US20030186974 Pyrrolyl- and imidazolyl-acid amide derivatives useful as inhibitors of PDE4 isozymes
10/02/2003US20030186960 Nervous system regeneration
10/02/2003US20030186958 Viricides, vision defects, oral diseases, antiarthritic agents, multiple sclerosis, anticancer agents
10/02/2003US20030186936 Gene therapy; lyases; hyaluronidase; anticancer agents (retinoblastomas); kits
10/02/2003US20030186931 Comprises trehalose; for treatment of Gougerot-Sjogren Syndrome
10/02/2003US20030186928 Method for reducing intraocular pressure
10/02/2003US20030186927 Such as uridine 5'-diphosphoric acid for corneal epithelial migration promotion
10/02/2003US20030186902 Use of a pituitary tumor transforming gene peptide which has the ability to regulate endogenous PTTG1 expression and/or function in a dominant negative manner
10/02/2003US20030186897 Derivatives of branched-chain lipophilic molecules and uses thereof
10/02/2003US20030186842 Contacting a cell population with an inhibiting effective amount of a reagent that suppresses the protease activity of at least one member of the interleukin-1beta- converting enzyme (ICE)/CED-3 family
10/02/2003US20030186825 Contact lens wetting solution
10/02/2003US20030186337 Novel death associated proteins, and THAP1 and PAR4 pathways in apoptosis control
10/02/2003US20030186308 Prostacyclin-stimulating factor-2
10/02/2003US20030185834 Administering an anti-angiogenesis factor to localize in the choroidal neovasculature; administering photosensitizer; photodynamic therapy by irradiating with laser light
10/02/2003CA2480388A1 Methods and compounds for prevention and treatment of elevated intraocular pressure and related conditions
10/02/2003CA2480385A1 Alkoxypyridine derivatives as nitric oxide synthase inhibitors
10/02/2003CA2479880A1 Combination comprising an hmg-coa reductase inhibittor and an insulin secretor enhancer or an insulin sensitizer
10/02/2003CA2479718A1 Analgesics for nasal administration
10/02/2003CA2479686A1 A composition for treating pollinosis comprising an extract of sasa albo-marginata
10/02/2003CA2479167A1 Raav vector compositions and methods for the treatment of choroidal neovascularization
10/02/2003CA2478913A1 Substituted chroman derivatives having cytochrome p450rai inhibitory activity
10/02/2003CA2478839A1 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof
10/02/2003CA2477651A1 Kinase inhibitors
10/02/2003CA2474637A1 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane nmda, 5ht3, and neuronal nicotinic receptor antagoni sts
10/01/2003EP1348707A1 Pyrazolo[4,3-d]pyrimidines, processes for their preparation and methods for therapy
10/01/2003EP1348437A2 Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
10/01/2003EP1348434A1 Use of pyridyl amides as inhibitors of angiogenesis
10/01/2003EP1348427A1 Ophthalmic compositions containing galactomannan polymers and borate
10/01/2003EP1347990A2 Peptide mit inhibierender aktivität zur produktion von stickstoffmonoxid
10/01/2003EP1347980A1 Compounds specific to adenosine-a1,-a2a, and- a3-receptor and uses thereof
10/01/2003EP1347966A1 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives
10/01/2003EP1347780A1 Compositions of n-(methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridylsulfonamide and cyclic oligosaccharides
10/01/2003EP1347762A2 Pharmaceutical formulation containing thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives (2)
10/01/2003EP1347761A2 Pharmaceutical formulation containing thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives
10/01/2003EP1347755A2 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
10/01/2003EP1202954B1 Novel aminobenzophenones
10/01/2003EP1056467B1 Method for the treatment of diseases or disorders of the inner ear
10/01/2003EP0999854B1 Switchable viscoelastic systems containing galactomannan polymers and borate
10/01/2003EP0999825B1 Ophthalmic compositions containing galactomannan polymers and borate
10/01/2003EP0772596B1 INDOLIZINE sPLA2 INHIBITORS
10/01/2003EP0662087B1 Method for purifying retinal pigmented epithelium derived neurotrophic factor
10/01/2003CN1446229A Somatostatin analogues
10/01/2003CN1446214A Cinnoline compounds
10/01/2003CN1446212A Quinoline derivatives having VEGF inhibiting activity
10/01/2003CN1446202A 2-aminopyridine compounds and use thereof as drugs
10/01/2003CN1446193A Aminoadamantane derivatives as therapeutic agents
10/01/2003CN1446092A Aqueous pharmaceutical compositions
09/2003
09/30/2003US6627662 3-amino-propoxyphenyl derivatives (I)
09/30/2003US6627656 Method of treatment using phenyl and biaryl derivatives as prostaglandin E inhibitors and compounds useful therefore
09/30/2003US6627649 (2S)-1-((2R,3S)-5-chloro-3-(2-chlorophenyl)-1-(3,4 -dimethoxybenzenesulfonyl)-3-hydroxy-2,3-dihydro-1H-indole-2 -carbonyl)pyrrolidine-2-carboxamide, a selective V1a arginine vasopressin receptor antagonist, in combination with the
09/30/2003US6627645 Muscarinic agonists
09/30/2003US6627626 Antiinflammation agents and antiarthritic agents colon cancer, and Alzheimer's disease in mammals, preferably humans, dogs, cats and livestock animals.
09/30/2003US6627620 Composition set and kit for use in intraocular surgery
09/30/2003US6627439 Cancer diagnosis, therapy; Dna vaccine
09/30/2003US6627210 Alpha-2-adrenergic agonist component is selected from the group consisting of imino-imidazolines, imidazolines, imidazoles, azepines, thiazines, oxazolines, guanidines, catecholamines and derivatives or mixtures
09/30/2003US6627195 Binding agents to CD23
09/30/2003CA2254750C Inhibition of matrix metalloproteases by 2-(.omega.-aroylalkyl)-4-biaryl-oxobutyric acids
09/25/2003WO2003078465A1 The use of an epitope of vascular endothelial growth factor receptor kdr/flk-1
09/25/2003WO2003078453A1 Mutants of the p4 protein of nontypable haemophilus influenzae with reduced enzymatic activity
09/25/2003WO2003078425A1 Novel crystalline form of 5-[4-[[3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl]methoxy]benzyl]thiazolidine-2,4-dione potassium salt
09/25/2003WO2003078422A1 Novel pyridone derivative
09/25/2003WO2003078419A1 N-substituted benzothiophenesulfonamide derivative
09/25/2003WO2003078415A1 Cyclic hemiacetal derivative and use thereof
09/25/2003WO2003078413A1 Thiazole derivatives having cb1-antagonistic, agonistic or partial agonistic activity
09/25/2003WO2003078404A1 Pyrimidine derivatives
09/25/2003WO2003078395A1 Piperidine derivatives useful as modulators of chemokine receptor activity
09/25/2003WO2003077952A1 Topical composition comprising a cyclofructan, a carrier and a drug
09/25/2003WO2003077915A1 Use of rapamycin for inhibiting of cell death
09/25/2003WO2003077914A1 N3 alkylated benzimidazole derivatives as mek inhibitors
09/25/2003WO2003077910A1 Methods of treatment with selective ep4 receptor agonists
09/25/2003WO2003077908A1 Use of selective ep4 receptor agonists for the treatment of liver failure, loss of patency of the ductus arteriosus, glaucoma or ocular hypertension
09/25/2003WO2003077905A1 Use of an l-ascorbic acid salt to prepare a pharmaceutical composition for ophtalmic topical use capable of improving the level of l-ascorbic acid in the eye
09/25/2003WO2003077901A1 Preventing and/or treating cardiovascular disease and/or associated heart failure
09/25/2003WO2003077898A1 Agents for corneal or intrastromal administration to treat or prevent disorders of the eye
1 ... 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 ... 531